Related Experiment Video
Updated: May 12, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis
Mary A Duffy1, Virginia Hernandez-Santiago, Gillian Orange
1Population Health Sciences Division, Medical Research Institute, University of Dundee, Dundee, UK.
Insights
Previous trimethoprim prescriptions in children significantly increase the risk of trimethoprim-resistant E. coli infections. Recent antibiotic use is strongly linked to developing antibiotic resistance in pediatric urinary tract infections.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial resistance
- Public health
Background:
- Antibiotic resistance is a significant global health threat.
- Pediatric antibiotic use and resistance patterns are understudied.
- Urinary tract infections (UTIs) are common in children.
Purpose of the Study:
- To examine the link between prior trimethoprim prescribing and trimethoprim resistance in pediatric E. coli urinary isolates.
- To understand the impact of antibiotic use on resistance development in children.
Main Methods:
- Retrospective population cohort study in Tayside, Scotland (2004-2009).
- Analysis of linked microbiology and dispensed prescribing data for 1373 children (≤16 years).
- Multilevel modeling to assess the association between previous trimethoprim prescription and subsequent resistance.
Main Results:
- Trimethoprim resistance in E. coli isolates was prevalent (26.6%).
- Previous trimethoprim prescription was significantly associated with trimethoprim-resistant E. coli.
- More recent trimethoprim prescriptions showed a stronger association with resistance.
Conclusions:
- Trimethoprim prescribing directly impacts future resistance in pediatric UTIs.
- Appropriate antibiotic selection and duration are crucial for children.
- Consider alternative antibiotics for pediatric UTIs if trimethoprim was used recently.
Background:
Antibiotic resistance is a growing concern and antibiotic usage the main contributing factor, but there are few studies examining antibiotic use and resistance in children.
Aim:
To investigate the association between previous trimethoprim prescribing and resistance in urinary Escherichia coli (E. coli) isolates in children.
Design And Setting:
Retrospective, population cohort study in Tayside, Scotland.
Method:
Multilevel modelling of linked microbiology and dispensed prescribing data for 1373 ≤16-year-olds with E. coli urinary isolates in 2004-2009, examining the association between prior trimethoprim prescription and subsequent trimethoprim resistance in people with urinary E. coli isolates.
Results:
Trimethoprim resistance was common (26.6%, 95% confidence interval [CI] = 24.6 to 28.6). Previous trimethoprim prescription was associated with subsequent culture of trimethoprim-resistant E. coli, with more recent prescription being more strongly associated with resistance. After adjusting for the number of previous E. coli isolates and sample year, trimethoprim prescribing in the previous 84 days remained significantly associated with culturing trimethoprim-resistant E. coli (adjusted OR 4.71, 95% CI = 1.83 to 12.16 for the previous 15-28 days versus never prescribed; adjusted OR 3.16, 95% CI = 1.63 to 6.13 for the previous 29-84 days); however, associations were not statistically significant for longer periods since prior exposure.
Conclusion:
Trimethoprim prescription has implications for future resistance in individual children, as well as at population level. Clinicians must ensure appropriateness of treatment choice and duration, and alternative antibiotics should be considered for childhood urinary tract infections if trimethoprim has been prescribed in the preceding 3 months.
More Related Videos
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Mechanism of Antibiotic Resistance in MRSA
Urine Studies II: Urine Culture and Sensitivity Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction

